Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07419009

Feasibility of Modulating Cognitive Control in OCD

This study tests out procedures to look at whether a type of brain stimulation called transcranial magnetic stimulation impacts flexible shifts in behavior in obsessive-compulsive disorder (OCD). This study examines whether study procedures are feasible and acceptable to people participating in the study, but does not determine whether this type of brain stimulation causes changes.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Current primary DSM-5 OCD diagnosis and current Y-BOCS total score of ≥16 (OCD group, only) or no current diagnosis of an emotional disorder, and no known history of OCD, PTSD, anxiety disorder(s), or recurrent major depressive disorder (Healthy participant group, only)
  • 18-60 years of age
  • ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent
  • psychotherapy and/or psychiatric medication use remain stable for 6 weeks prior to study entry

Exclusion criteria

  • Presence of current psychiatric diagnosis (healthy control group, only)
  • active substance use disorder
  • history of mania or hypomania, or lifetime presence of significant psychotic symptoms
  • active suicidal or homicidal ideation
  • use of medications known to reduce seizure threshold (e.g., stimulants)
  • organic brain disease or injury representing a contraindication to TMS
  • any health problems that would interfere with safe and/or practical study participation, including contraindications to TMS (e.g., seizure disorder, presence of metal hardware that would come in close contact with the discharging coil)
  • current pregnancy or planning to become pregnant during the study period

Treatment and study plan

continuous theta-burst transcranial magnetic stimulation (cTBS)

Device

3 consecutive daily sessions of cTBS

Primary outcomes

  1. Rate of enrollment

    Time frame: At study enrollment

    Percent of screened participants who are determined to be eligible and enrolled.

Secondary outcomes

  1. Rates of visit completion

    Time frame: From enrollment to date of post-TMS study visit (approximately 1 week)

    Percent (%) of enrolled participants completing each study visit

  2. Peak cTBS intensity tolerated

    Time frame: From enrollment to end of TMS sessions (approximately 1 week)

    Average of peak intensity (up to target intensity) tolerated during cTBS sessions

Sponsors and collaborators

Lead sponsor

Dartmouth-Hitchcock Medical Center

Other

Registry information

Official study title

Evaluating Frontal Pole as a Window to Modulation of Cognitive Control in OCD

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 18, 2026
Registry last updated
May 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.